2025 SMID Cap Biotech Outlook_ Get Closer To What You Can Measure

更多资料加入知识星球：水木调研纪要 关注公众号：水木纪要 M Idea - JAZZ (+45% to our $175 price target): Ziihera for HER2+ BTC. The 2L BTC commercial launch is underway following Ziihera accelerated approval on November 20, 2024. Further out, we expect additional Ziihera topline growth could come from gastroesophageal adenocarcinoma (GEA) and the pivotal HERIZON-GEA-01 topline in 2Q25. | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|--------------------------------------------------------------- ...